Influence of social deprivation on morbidity and all-cause mortality of cardiometabolic multi-morbidity: a cohort analysis of the UK Biobank cohort.
All-cause mortality
Cardiometabolic disease
Cardiometabolic multimorbidity
Townsend deprivation index
UK Biobank
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
07 11 2023
07 11 2023
Historique:
received:
27
01
2023
accepted:
17
10
2023
medline:
8
11
2023
pubmed:
7
11
2023
entrez:
6
11
2023
Statut:
epublish
Résumé
The relation of social deprivation with single cardiometabolic disease (CMD) was widely investigated, whereas the association with cardiometabolic multi-morbidity (CMM), defined as experiencing more than two CMDs during the lifetime, is poorly understood. We analyzed 345,417 UK Biobank participants without any CMDs at recruitment to study the relation between social deprivation and four CMDs including type II diabetes (T2D), coronary artery disease (CAD), stroke and hypertension. Social deprivation was measured by Townsend deprivation index (TDI), and CMM was defined as occurrence of two or more of the above four diseases. Multivariable Cox models were performed to estimate hazard ratios (HRs) per one standard deviation (SD) change and in quartile (Q1-Q4, with Q1 as reference), as well as 95% confidence intervals (95% CIs). During the follow up, 68,338 participants developed at least one CMD (median follow up of 13.2 years), 16,225 further developed CMM (median follow up of 13.4 years), and 18,876 ultimately died from all causes (median follow up of 13.4 years). Compared to Q1 of TDI (lowest deprivation), the multivariable adjusted HR (95%CIs) of Q4 (highest deprivation) among participants free of any CMDs was 1.23 (1.20 ~ 1.26) for developing one CMD, 1.42 (1.35 ~ 1.48) for developing CMM, and 1.34 (1.27 ~ 1.41) for all-cause mortality. Among participants with one CMD, the adjusted HR (95%CIs) of Q4 was 1.30 (1.27 ~ 1.33) for developing CMM and 1.34 (1.27 ~ 1.41) for all-cause mortality, with HR (95%CIs) = 1.11 (1.06 ~ 1.16) for T2D patients, 1.07 (1.03 ~ 1.11) for CAD patients, 1.07 (1.00 ~ 1.15) for stroke patients, and 1.24 (1.21 ~ 1.28) for hypertension patients. Among participants with CMM, TDI was also related to the risk of all-cause mortality (HR of Q4 = 1.35, 95%CIs 1.28 ~ 1.43). We revealed that people living with high deprived conditions would suffer from higher hazard of CMD, CMM and all-cause mortality.
Sections du résumé
BACKGROUND
The relation of social deprivation with single cardiometabolic disease (CMD) was widely investigated, whereas the association with cardiometabolic multi-morbidity (CMM), defined as experiencing more than two CMDs during the lifetime, is poorly understood.
METHODS
We analyzed 345,417 UK Biobank participants without any CMDs at recruitment to study the relation between social deprivation and four CMDs including type II diabetes (T2D), coronary artery disease (CAD), stroke and hypertension. Social deprivation was measured by Townsend deprivation index (TDI), and CMM was defined as occurrence of two or more of the above four diseases. Multivariable Cox models were performed to estimate hazard ratios (HRs) per one standard deviation (SD) change and in quartile (Q1-Q4, with Q1 as reference), as well as 95% confidence intervals (95% CIs).
RESULTS
During the follow up, 68,338 participants developed at least one CMD (median follow up of 13.2 years), 16,225 further developed CMM (median follow up of 13.4 years), and 18,876 ultimately died from all causes (median follow up of 13.4 years). Compared to Q1 of TDI (lowest deprivation), the multivariable adjusted HR (95%CIs) of Q4 (highest deprivation) among participants free of any CMDs was 1.23 (1.20 ~ 1.26) for developing one CMD, 1.42 (1.35 ~ 1.48) for developing CMM, and 1.34 (1.27 ~ 1.41) for all-cause mortality. Among participants with one CMD, the adjusted HR (95%CIs) of Q4 was 1.30 (1.27 ~ 1.33) for developing CMM and 1.34 (1.27 ~ 1.41) for all-cause mortality, with HR (95%CIs) = 1.11 (1.06 ~ 1.16) for T2D patients, 1.07 (1.03 ~ 1.11) for CAD patients, 1.07 (1.00 ~ 1.15) for stroke patients, and 1.24 (1.21 ~ 1.28) for hypertension patients. Among participants with CMM, TDI was also related to the risk of all-cause mortality (HR of Q4 = 1.35, 95%CIs 1.28 ~ 1.43).
CONCLUSIONS
We revealed that people living with high deprived conditions would suffer from higher hazard of CMD, CMM and all-cause mortality.
Identifiants
pubmed: 37932741
doi: 10.1186/s12889-023-17008-5
pii: 10.1186/s12889-023-17008-5
pmc: PMC10629082
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2177Informations de copyright
© 2023. The Author(s).
Références
EBioMedicine. 2022 Oct;84:104282
pubmed: 36174399
JAMA Intern Med. 2016 Aug 1;176(8):1053-4
pubmed: 27367180
Eur J Neurol. 2021 Mar;28(3):800-808
pubmed: 33098727
BMJ. 2019 Apr 17;365:l1495
pubmed: 30995986
Int J Epidemiol. 2004 Dec;33(6):1389-97
pubmed: 15319402
Int J Epidemiol. 2011 Jun;40(3):804-18
pubmed: 21335614
Med J Aust. 2011 Jul 4;195(1):10-4
pubmed: 21728934
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034
pubmed: 28641372
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Am J Public Health. 2003 Jul;93(7):1137-43
pubmed: 12835199
Lancet Public Health. 2023 May;8(5):e329-e338
pubmed: 37062296
Am J Epidemiol. 2021 Feb 1;190(2):295-304
pubmed: 33524122
BMJ. 2020 Feb 12;368:m131
pubmed: 32051121
Mayo Clin Proc. 2022 Jan;97(1):57-67
pubmed: 34996566
BMC Med. 2022 Aug 18;20(1):273
pubmed: 35978398
Am J Clin Nutr. 2021 Nov 8;114(5):1837-1846
pubmed: 34375391
Nat Rev Nephrol. 2019 Jun;15(6):367-385
pubmed: 31015582
PLoS One. 2020 Apr 20;15(4):e0231878
pubmed: 32311000
Mayo Clin Proc. 2022 Jun;97(6):1108-1113
pubmed: 35300876
Popul Health Metr. 2021 Jan 7;19(1):1
pubmed: 33413469
J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E51-E64
pubmed: 31016268
BMC Public Health. 2014 Dec 13;14:1264
pubmed: 25495106
Diabetes Metab. 2020 Apr;46(2):89-99
pubmed: 31759171
Am J Epidemiol. 2007 Sep 15;166(6):646-55
pubmed: 17615092
Curr Diabetes Rev. 2011 May;7(3):148-58
pubmed: 21418003
Prog Neuropsychopharmacol Biol Psychiatry. 2023 Apr 20;123:110700
pubmed: 36566903
JACC CardioOncol. 2022 Mar 15;4(1):69-81
pubmed: 35492825
Biol Psychiatry. 2021 May 1;89(9):888-895
pubmed: 33500177
Mayo Clin Proc. 2018 Jul;93(7):857-866
pubmed: 29801777
Dtsch Arztebl Int. 2021 Jun 11;118(23):397-402
pubmed: 34304754
Am Heart J. 2018 Oct;204:109-118
pubmed: 30092412
BMC Public Health. 2014 Dec 23;14:1319
pubmed: 25539758
Circulation. 2015 Sep 1;132(9):873-98
pubmed: 26240271
Soc Sci Med. 2017 Sep;189:138-144
pubmed: 28802118
BMJ. 2021 Apr 14;373:n604
pubmed: 33853828
N Engl J Med. 2018 Jun 28;378(26):2456-2458
pubmed: 29949490
BMC Med. 2019 Jun 12;17(1):108
pubmed: 31186007
Eur Heart J. 2021 Apr 21;42(16):1582-1591
pubmed: 33527989
Respir Res. 2023 May 23;24(1):137
pubmed: 37221593
Qual Life Res. 2018 Aug;27(8):2127-2135
pubmed: 29761348
BMC Med. 2022 Feb 24;20(1):79
pubmed: 35655214
Lancet Neurol. 2015 Dec;14(12):1206-18
pubmed: 26581971
Annu Rev Med. 2020 Jan 27;71:163-175
pubmed: 31986080
Eur Respir J. 2019 Jul 25;54(1):
pubmed: 31285306
Stat Med. 1989 May;8(5):551-61
pubmed: 2657958
Chin Med J (Engl). 2022 Mar 20;135(6):648-657
pubmed: 35191418
J Psychosom Res. 2022 Sep;160:110978
pubmed: 35763943
J Am Heart Assoc. 2022 Sep 6;11(17):e025936
pubmed: 36036170
Int J Epidemiol. 2018 Feb 1;47(1):226-235
pubmed: 29040562
J Epidemiol Community Health. 2022 Mar;76(3):268-273
pubmed: 34789553
Autoimmun Rev. 2014 Jun;13(6):641-54
pubmed: 24418307
BMC Public Health. 2017 Aug 2;18(1):86
pubmed: 28764733
BMJ Open Diabetes Res Care. 2020 Jul;8(1):
pubmed: 32611580
JAMA. 2015 Jul 7;314(1):52-60
pubmed: 26151266
Biol Psychiatry. 2021 May 1;89(9):839-841
pubmed: 33858589
Lancet Public Health. 2018 Apr;3(4):e185-e193
pubmed: 29550372
EClinicalMedicine. 2021 Jun 14;37:100960
pubmed: 34386746
J Am Coll Cardiol. 2018 May 15;71(19):2149-2161
pubmed: 29747836
Nat Commun. 2019 Dec 16;10(1):5741
pubmed: 31844048